581
Views
9
CrossRef citations to date
0
Altmetric
Review

Molecular diagnosis and molecular profiling to detect treatment-resistant ovarian cancer

, , , &
Pages 769-782 | Received 31 Jul 2015, Accepted 09 May 2016, Published online: 27 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ebru Kale, Ahmet Kale, Kubra Bozali, Ahmet Sadik Gulgec, Mucahit Ozdemir, Bahattin Yalcin & Eray Metin Guler. (2023) TQ-Ox, a novel synthetic derivative of thymoquinone on ovarian cancer cells in vitro. Natural Product Research 37:18, pages 3015-3024.
Read now
Lei Li, Jinguang Wu, Limin Yang, Huizi Wang, Yizhuang Xu & Keng Shen. (2021) Fourier Transform Infrared Spectroscopy: An Innovative Method for the Diagnosis of Ovarian Cancer. Cancer Management and Research 13, pages 2389-2399.
Read now

Articles from other publishers (7)

Yuqing Shen, Hui Lin, Kelie Chen, Wanzhong Ge, Dajing Xia, Yihua Wu & Weiguo Lu. (2022) High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer. Journal of Ovarian Research 15:1.
Crossref
Mohamed Hammad, Yvonne Cornejo, Linda Flores, Caitlyn Hyde, Hoi Wa Ngai, Min Li, Thanh H. Dellinger, Jianming Lu, Nanhai G. Chen, Rachael Mooney, Karen S. Aboody & Yuman Fong. (2020) Novel Chimeric Poxvirus CF17 Improves Survival in a Murine Model of Intraperitoneal Ovarian Cancer Metastasis. Molecular Therapy - Oncolytics 19, pages 278-282.
Crossref
Cancan Zhu, Anzhong Hu, Junsheng Cui, Ke Yang, Xinchao Zhu, Yong Liu, Guoqing Deng & Ling Zhu. (2019) A Lab-on-a-Chip Device Integrated DNA Extraction and Solid Phase PCR Array for the Genotyping of High-Risk HPV in Clinical Samples. Micromachines 10:8, pages 537.
Crossref
Basmina Parmakhtiar, Robert A. Burger, Jai-Hyun Kim & John P. Fruehauf. (2019) HIF Inactivation of p53 in Ovarian Cancer Can Be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity. Molecular Cancer Research 17:8, pages 1675-1686.
Crossref
Anna Erol, Magdalena Niemira & Adam Jacek Krętowski. (2019) Novel Approaches in Ovarian Cancer Research against Heterogeneity, Late Diagnosis, Drug Resistance, and Transcoelomic Metastases. International Journal of Molecular Sciences 20:11, pages 2649.
Crossref
Irene Kuhn, Maxine Bauzon, Nicola Green, Len Seymour, Kerry Fisher & Terry Hermiston. (2017) OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution. Molecular Therapy - Oncolytics 4, pages 55-66.
Crossref
Yannan Chen, Xia Wang, Chengwei Duan, Jie Chen, Ming Su, Yunfeng Jin, Yan Deng, Di Wang, Caiwen Chen, Linsen Zhou, Jialin Cheng, Wei Wang & Qinghua Xi. (2016) Loss of TAB3 expression by shRNA exhibits suppressive bioactivity and increased chemical sensitivity of ovarian cancer cell lines via the NF-κB pathway . Cell Proliferation 49:6, pages 657-668.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.